Log in

002317 Guangdong Zhongsheng Pharmaceutical Co., Ltd. SZSE · China

Guangdong Zhongsheng Pharmaceutical Co. (002317) news

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002317, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Guangdong Zhongsheng Pharmaceutical Co. news

We have not published a story on Guangdong Zhongsheng Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Guangdong Zhongsheng Pharmaceutical Co.

What is the ticker symbol of Guangdong Zhongsheng Pharmaceutical Co.?

Guangdong Zhongsheng Pharmaceutical Co., Ltd. trades under the ticker 002317 on SZSE.

Where is Guangdong Zhongsheng Pharmaceutical Co. listed?

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is listed on SZSE.

Which country or territory is Guangdong Zhongsheng Pharmaceutical Co. listed under?

Our directory records Guangdong Zhongsheng Pharmaceutical Co., Ltd. under China.

What does Guangdong Zhongsheng Pharmaceutical Co. do?

Our directory classifies Guangdong Zhongsheng Pharmaceutical Co., Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Guangdong Zhongsheng Pharmaceutical Co.?

The ISIN recorded for Guangdong Zhongsheng Pharmaceutical Co., Ltd. is CNE100000HW4.

Does aibio.space cover Guangdong Zhongsheng Pharmaceutical Co.?

aibio.space lists Guangdong Zhongsheng Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Guangdong Zhongsheng Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Guangdong Zhongsheng Pharmaceutical Co.: HBM Holdings, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Hunan Hansen Pharmaceutical Co., Lanzhou Foci Pharmaceutical Co., Shanxi Zhendong Pharmaceutical Co., China Shineway Pharmaceutical Group.

Investor discussion: Guangdong Zhongsheng Pharmaceutical Co.

Members talk about Guangdong Zhongsheng Pharmaceutical Co. (002317). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:002317 on TradingView.

Listing details

Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 002317, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Ticker
002317
Listing
SZSE
Country or territory
China
Business scope
Biopharma / pharmaceutical profile checked
ISIN
CNE100000HW4
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.